The study aims to evaluate the risk of developing acne in patients with atopic dermatitis receiving JAK inhibitors compared to Th2 cytokine inhibitors.
Cohort study design
Patient population includes adults with atopic dermatitis
Comparison of acne incidence between JAK and Th2 cytokine inhibitors
Increased risk of acne observed in patients on JAK inhibitors compared to those on Th2 cytokine inhibitors
Specific quantitative data not provided, but significant differences noted
Abstract
This cohort study evaluates the risk of acne in adult patients with atopic dermatitis who started treatment with Janus kinase inhibitors compared with Th2 cytokine inhibitors.